A Randomized, Double-Blind, Multicenter Trial Comparing Transdermal Scopolamine Plus Ondansetron to Ondansetron Alone for the Prevention of Postoperative Nausea and Vomiting in the Outpatient Setting
- Post by: Claudio Pergolizzi
- February 18, 2020
- Comments off
Categories: